Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants
about
Pentoxifylline for the prevention of bronchopulmonary dysplasia in preterm infantsEarly (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infantsInhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infantsInhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonatesEarly administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonatesLate (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infantsSystemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infantsPentoxifylline for the prevention of bronchopulmonary dysplasia in preterm infantsCorticosteroids for treating hypotension in preterm infantsIntratracheal instillation of corticosteroids using surfactant as a vehicle for the prevention of chronic lung disease in preterm infants with respiratory distress syndromeAntiretrovirals for reducing the risk of mother-to-child transmission of HIV infectionModerately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infantsSteroids and bronchodilators for acute bronchiolitis in the first two years of life: systematic review and meta-analysisPharmacologic interventions for the prevention and treatment of retinopathy of prematurityAn update on pharmacologic approaches to bronchopulmonary dysplasiaConcordance of effects of medical interventions on hospital admission and readmission rates with effects on mortalityUtilization of inhaled corticosteroids for infants with bronchopulmonary dysplasiaEarly administration of inhaled corticosteroids for preventing chronic lung disease in very low birth weight preterm neonates.Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis.Association between postnatal dexamethasone for treatment of bronchopulmonary dysplasia and brain volumes at adolescence in infants born very preterm.[Predictors of extubation failure and reintubation in newborn infants subjected to mechanical ventilation].Health related quality of life after extremely preterm birth: a matched controlled cohort study.Hyperglycemia increases the risk of death in extremely preterm baboons.Death or neurodevelopmental impairment at 18 to 22 months corrected age in a randomized trial of early dexamethasone to prevent death or chronic lung disease in extremely low birth weight infants.A systematic review of randomized controlled trials for the prevention of bronchopulmonary dysplasia in infants.Glucocorticoids promote neural progenitor cell proliferation derived from human induced pluripotent stem cells.Targeting inflammation to prevent bronchopulmonary dysplasia: can new insights be translated into therapies?Bronchopulmonary dysplasia early changes leading to long-term consequences.Effect of dexamethasone on intelligence and hearing in preterm infants: a meta-analysis.Current pharmacologic approaches for prevention and treatment of bronchopulmonary dysplasia.Neurodevelopmental Outcomes of Extremely Preterm Infants Randomized to Stress Dose Hydrocortisone.Evidence-Based Neonatal Unit Practices and Determinants of Postnatal Corticosteroid-Use in Preterm Births below 30 Weeks GA in Europe. A Population-Based Cohort Study.Pilot randomized trial of hydrocortisone in ventilator-dependent extremely preterm infants: effects on regional brain volumes.Gestational dating by metabolic profile at birth: a California cohort studyImportance of gut microbiota in health and diseases of new born infants.Extreme prematurity and attention deficit: epidemiology and preventionNeonatal posthemorrhagic hydrocephalus from prematurity: pathophysiology and current treatment conceptsSteroids and injury to the developing brain: net harm or net benefit?Inflammatory injury to the neonatal brain - what can we do?Stopping the swinging pendulum of postnatal corticosteroid use.
P2860
Q24187852-24905EF1-DED8-4466-91B7-510E56BDD379Q24194710-41523491-D449-401F-A7DC-48B17C94A210Q24197845-49DA1255-37D8-4643-A44C-415D1AE021AEQ24197850-B687861D-E2C8-43A2-B24B-245870DA7EF4Q24197860-49973CD9-F4D0-41A4-A73E-C60FDC2D32B0Q24200447-3B603F31-2284-4171-A8C0-11C04AE36F4AQ24201323-A432FA44-14CB-443D-9942-A95C5C617FE3Q24201869-83AC56BE-5A4E-4DB4-92D1-D2E5F575D893Q24204029-1EAD21C6-4E58-4B29-BB58-9FB554851C82Q24235457-C1B83ADB-60EF-4799-9112-CBC30E46BC32Q24235500-0F2580FF-EC2D-4A22-9BA9-46EC4CB7282BQ24250284-BA87FD6A-289B-4B30-9AFB-7C30D4380FF0Q24624543-0D70B7B3-D8B5-44F4-BFC6-4B16250171EFQ26772889-929DF89E-3902-4974-B4B6-FEF08F75E1ADQ26825139-0D88E34A-4115-48C4-9CDD-99A5FCF2D36DQ27022171-62B81D32-0946-407F-AC3A-BA3CB255BC9BQ28542831-F833569B-6DB9-42E8-B514-8B5E85DA498CQ30239811-008ACFCD-D634-4788-951F-68C892B7002CQ33629374-D604DBEB-1B5B-4D4A-AE35-32CC6D49A977Q33642165-79E7D178-A244-49AF-9F1B-06C6E16F1087Q33653388-E1722DF6-F170-4924-812D-199F8994B548Q33951798-28AE38F3-68EE-4415-8DA8-D69037B361C4Q33956320-BCC67F8A-925C-4518-A831-96E13C5FF4CAQ33997780-32FC4CBF-6B6A-4887-8AC4-8E7C802F822AQ34123512-5FE01CEC-121A-4131-8553-3C83B65CFA49Q34241237-5AB36681-BA82-4B69-B01E-4E699C232B9BQ35070866-772BD47B-333D-4783-BAE0-63F2641BD2BCQ35077309-4EFD6424-4CF4-4FC4-8A23-28A9F23C0DADQ35245464-533C96EC-D86A-440F-A027-142DA630C793Q35675944-7A0BC10B-B57B-4992-94BC-9B926B126918Q35777319-F34C4145-6394-4FC2-A915-7956AC44C45EQ36257620-CAD6EC72-CAD1-4931-952E-27BAE3ABFCF7Q36721603-33481D4A-B581-4DAB-95B4-1F4F103E5356Q36770344-103A35E6-B570-45F9-B973-5CB69AB7A696Q37001049-7E477D50-2557-4A73-AEB0-C86EE365CAD6Q37182098-2E08713D-D9E8-4720-A27E-A8BCF087F680Q37347049-2634C012-6EF8-4FCF-A2C5-7C49CC581C19Q37373734-7B2B62F3-1907-4E83-AA93-CCFA5352CD4CQ37705471-84646D53-576A-45A4-A810-90C883F5327EQ43160711-0F738DC5-AC41-47CC-AFDF-2B0BFE83F8A9
P2860
Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Early (< 8 days) postnatal cor ...... ung disease in preterm infants
@ast
Early (< 8 days) postnatal cor ...... ung disease in preterm infants
@en
Early (< 8 days) postnatal cor ...... ung disease in preterm infants
@en-gb
Early (< 8 days) postnatal cor ...... ung disease in preterm infants
@nl
type
label
Early (< 8 days) postnatal cor ...... ung disease in preterm infants
@ast
Early (< 8 days) postnatal cor ...... ung disease in preterm infants
@en
Early (< 8 days) postnatal cor ...... ung disease in preterm infants
@en-gb
Early (< 8 days) postnatal cor ...... ung disease in preterm infants
@nl
prefLabel
Early (< 8 days) postnatal cor ...... ung disease in preterm infants
@ast
Early (< 8 days) postnatal cor ...... ung disease in preterm infants
@en
Early (< 8 days) postnatal cor ...... ung disease in preterm infants
@en-gb
Early (< 8 days) postnatal cor ...... ung disease in preterm infants
@nl
P2860
P3181
P1476
Early (< 8 days) postnatal cor ...... ung disease in preterm infants
@en
P2093
Richard A Ehrenkranz
P2860
P3181
P356
10.1002/14651858.CD001146.PUB3
P577
2010-01-20T00:00:00Z